SCHEMBL17866282

SCHEMBL17866282

NC(=O)NCC1CNCCO1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.49
TDP1 Q9NUW8 1/20 0.41
SLC6A2 P23975 7/20 0.38
SLC6A4 P31645 7/20 0.38
ADRA2C P18825 1/20 0.36
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 3/20 0.35
TP53 P04637 1/20 0.35
ALOX12 P18054 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SLC6A3 Q01959 2/20 0.34
CHEK2 O96017 1/20 0.34
ADRB2 P07550 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR2B P41595 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22776149 0.84 CHEK1 (0.45) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL734651 0.84 CHEK1 (0.45) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL4146870 0.84 CHEK1 (0.45) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL1501987 0.83 SLC6A2 (0.51) CHEK1SLC6A2SLC6A4ADRA2CUSP2
SCHEMBL16036125 0.83 SLC6A2 (0.51) CHEK1SLC6A2SLC6A4ADRA2CUSP2
Hydrochloric Acid SCHEMBL19692370 0.83 CHEK1 (0.44) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL27326370 0.83 SLC6A2 (0.51) CHEK1SLC6A2SLC6A4ADRA2CUSP2
SCHEMBL16035265 0.81 USP2 (0.41) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL28204462 0.81 USP2 (0.41) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2
SCHEMBL16035263 0.81 USP2 (0.41) CHEK1SLC6A2SLC6A4USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029539-B1 N-(piperidinyl)-urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of e.g. hypertension or inflammations UNIV CALIFORNIA (US) 2016-06-29 EP disclosed